House Committee rejects plan to create state board to review drug prices
A plan to create a new state board to review data on drug prices and set new payment limits for state-regulated plans failed Wednesday to advance out of committee.
To access this content, you must purchase 1 Year Health News Illinois Subscription or 1 Year Group Subscription - Up to 5 Users, or log in if you are a member.
